The National Organization for Medicines (EOF) has announced the recall of specific batches of a drug prescribed for osteoarthritis and musculoskeletal conditions.

The EOF’s detailed statement is as follows:

“Recall of batches 2407048, 2404030, 2402019, 2402016, 2311098, 2404029 of the pharmaceutical product PATH MUSCLE SOLU.TAB (4+1000)MG/TAB (EOF code 3175602).

Marketing Authorization Holder: DOC PHARMA AE

DECISION

Considering:

• Article 6, paragraph II, clause 8 of Law 1316/83, as amended by Article 25 of Law 3730/2008
• Voluntary recall No. 111559/25-09-2024 by the company DOC PHARMA AE
• The recall of batches 2407048, 2404030, 2402019, 2402016, 2311098, 2404029 of the pharmaceutical product PATH-MUSCLE, SOLU.TAB (4+1000) MG/TAB, due to out-of-specification laboratory results.

This decision is issued to support the voluntary recall by the manufacturing company.

DOC PHARMA AE, as the marketing authorization holder of the product in Greece, must immediately contact its customers to withdraw it from the market.

The recall records must be kept for at least five (5) years and made available to EOF upon request.”